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e studied the bradykinin-induced changes in
 
phosphoinositide composition of N1E-115 neu-
roblastoma cells using a combination of bio-
chemistry, microscope imaging, and mathematical modeling.
 
Phosphatidylinositol-4,5-bisphosphate (PIP
 
2
 
) decreased
over the ﬁrst 30 s, and then recovered over the following
2–3 min. However, the rate and amount of inositol-1,4,5-
trisphosphate (InsP
 
3
 
) production were much greater than
the rate or amount of PIP
 
2
 
 decline. A mathematical model
of phosphoinositide turnover based on this data predicted
that PIP
 
2
 
 synthesis is also stimulated by bradykinin, causing
an early transient increase in its concentration. This was
subsequently conﬁrmed experimentally. Then, we used
W
 
single-cell microscopy to further examine phosphoinositide
turnover by following the translocation of the pleckstrin
homology domain of PLC
 
 
 
1 fused to green ﬂuorescent
protein (PH-GFP). The observed time course could be
simulated by incorporating binding of PIP
 
2
 
 and InsP
 
3
 
 to
PH-GFP into the model that had been used to analyze the
biochemistry. Furthermore, this analysis could help to
resolve a controversy over whether the translocation of PH-
GFP from membrane to cytosol is due to a decrease in PIP
 
2
 
on the membrane or an increase in InsP
 
3
 
 in cytosol; by
computationally clamping the concentrations of each of
these compounds, the model shows how both contribute
to the dynamics of probe translocation.
 
Introduction
 
Phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
)* which represents
 
 
 
1% of membrane phospholipids, is the predominant
(
 
 
 
99%) doubly phosphorylated phosphoinositide in mam-
malian cells (Vanhaesebroeck et al., 2001). It plays important
roles in PLC-mediated cellular processes because hydrolysis
of PIP
 
2
 
 by PLC generates DAG and inositol 1,4,5-trisphos-
phate (InsP
 
3
 
; Berridge and Irvine, 1984; Berridge, 1993),
 
which serve as second messengers for intracellular Ca
 
2
 
 
 
mobilization and PKC activation, respectively. Recent papers
show PIP
 
2
 
 also plays important roles in membrane traffick-
ing (Huijbregts et al., 2000; Manifava et al., 2001; Martin,
2001), interactions with cytoskeletons (Nebl et al., 2000;
Rozelle et al., 2000; Sechi and Wehland, 2000; van Rheenen
and Jalink, 2002), and modulation of ion transporters and
channels (Czech, 2000; Hilgemann et al., 2001).
We have been interested in the activation of the PLC
signaling pathway, particularly in a neuronal context, and
have examined this extensively in a murine neuroblastoma
cell line, N1E-115. In these cells, activation of the endogen-
ously expressed bradykinin B2, a G protein–coupled receptor,
results in a significant elevation of the intracellular [Ca
 
2
 
 
 
]
and [InsP
 
3
 
] (Fink et al., 1999a, 2000), and M current inhib-
ition (Higashida and Brown, 1987). We have found that M
current inhibition does depend on activation of PLC, but
has much slower kinetics than either InsP
 
3
 
 or Ca
 
2
 
 
 
 (Xu and
Loew, 2003). Also recently, it has been shown that membrane
PIP
 
2
 
 level plays an important role in M current modulation
(Suh and Hille, 2002; Zhang et al., 2003).
Although InsP
 
3
 
 increase is a direct consequence of PIP
 
2
 
hydrolysis induced by PLC activation, it was noted in several
papers that the InsP
 
3
 
 kinetics are generally more rapid
compared with the decrease and subsequent recovery in
membrane PIP
 
2
 
 (Kaya et al., 1989; Willars et al., 1998). It
should be pointed out that the level of cellular PIP
 
2
 
 is actually
regulated by the balance between the degradative and synthetic
enzymes. The recovery of membrane PIP
 
2
 
 is probably mediated
by PIP
 
2
 
 resynthesis at the plasma membrane. The majority
of PIP
 
2
 
 is synthesized via the sequential phosphorylation of
phosphatidylinositol (PI) at the 4
 
 
 
 position by PI 4-kinases
to produce PI 4-phosphate, and then at the 5
 
 
 
 position by
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*Abbreviations used in this paper: GTP
 
 
 
S, guanosine 5
 
 
 
-
 
O
 
-(3-thiotriphos-
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type I phosphoinositide 5-kinases (for reviews see Toker,
1998; Tolias and Cantley, 1999). Recently, it has been
found that PIP
 
2
 
 can also be synthesized via the phosphoryla-
tion of PI 5-phosphate at the 4
 
 
 
 position by type II phos-
phoinositide 5-kinases (Rameh et al., 1997). On the other
hand, other than PLC, the degradation of PIP
 
2
 
 can be medi-
ated either by PI 3-kinases or PIP
 
2
 
 5-phosphatases such as
synaptojanin (Mitchell et al., 1996; Nemoto et al., 1997;
Sakisaka et al., 1997; Takenawa et al., 1999).
It has been noted that activation of PLC by 
 
 
 
1-adrenergic
and muscarinic agonists caused an increased 
 
32
 
P incorpora-
tion into polyphospho-PIs in myocardium (Kiss and Farkas,
1975; Quist, 1982; Quist and Sanchez, 1983; Sekar and
Roufogalis, 1984), as well as an increased generation of
InsP
 
3
 
 (Mitchell et al., 1981). Additionally, it has been found
that both InsP
 
3
 
 and PIP
 
2
 
 increase at the time of fertiliza-
tion in sea urchin, 
 
Xenopus
 
, and mouse eggs (Turner et al.,
1984; Ciapa et al., 1992; Stith et al., 1993, 1994; Snow et
al., 1996; Halet et al., 2002), and during the stimulation
of platelets with thrombin (Lassing and Lindberg 1990).
All these findings suggest that hydrolysis and synthesis of
plasma membrane PIP
 
2
 
 may be tightly coupled such that
PIP
 
2
 
 synthesis rapidly compensates for, or is independently
stimulated by, its hydrolysis. Moreover, Chahwala et al.
(1987) found that the guanine nucleotide analogue gua-
nosine 5
 
 
 
-
 
O
 
-(3-thiotriphosphate) (GTP
 
 
 
S), which could
stimulate G proteins, activated PLC in [
 
3
 
H]inositol-labeled
fibroblast cells. They also found that the GTP
 
 
 
S-induced
increase in InsP
 
3
 
 was 10 times over the decrease in PIP
 
2
 
, sug-
gesting that a stimulated PIP
 
2
 
 synthesis by PI and PIP ki-
nases might accompany activation of PLC.
Recently, a GFP fusion protein, which consists of the
pleckstrin homology (PH) domain of PLC
 
 
 
1 fused to GFP
(PH-GFP), was developed as a probe for PIP
 
2
 
 in single cells
(Stauffer et al., 1998; Varnai and Balla, 1998). This indica-
tor has a high affinity for PIP
 
2
 
 and InsP
 
3
 
 (Rebecchi et al.,
1992; Lemmon et al., 1995; Kavran et al., 1998) because of
multiple hydrogen bond formations between its PH do-
main residues and the 4-and 5-phosphates on the inositol
ring (Ferguson et al., 1995). The expressed fluorescent
probe predominantly associates with the plasma membrane
in unstimulated cells (consistent with the distribution of
PIP
 
2
 
 in mammalian cells), and translocates to the cytosol
on activation of PLC. Because PLC
 
 
 
-PH shows 10–20-fold
higher affinity for InsP
 
3
 
 than PIP
 
2
 
 in vitro (Hirose et al.,
1999; McLaughlin et al., 2002), there are disputes about
whether the translocation of PH-GFP from membrane to
cytosol is due to a decrease in membrane PIP
 
2
 
 level or an
increase in cytosolic InsP
 
3
 
. Although Halet et al. (2002)
and van der Wal et al. (2001) showed that 10–100 
 
 
 
M of
photoreleased InsP
 
3
 
 was required to induce the transloca-
tion of PH-GFP from the plasma membrane, suggesting
physiological increases of InsP
 
3
 
 on activation of PLC (e.g.,
3 
 
 
 
M in N1E-115 cells, Fink et al., 1999a, 2000; or 0.3
 
 
 
M in smooth muscle cells, Fink et al., 1999b) could not
be solely responsible for translocation of PH-GFP; Hirose
et al. (1999) found intracellular injection of small amount
of InsP
 
3
 
 (
 
 
 
10 
 
 
 
M) caused significant translocation of PH-
GFP; they also showed that rapid degradation of InsP
 
3
 
 by
overexpression of an InsP
 
3
 
 5-phosphatase abolished ago-
 
nist-induced PH-GFP translocation (Hirose et al., 1999;
Okubo et al., 2001), suggesting translocation of PH-GFP
was monitoring changes in InsP
 
3
 
.
In this paper, we compared biochemical experiments mea-
suring the kinetics of the bradykinin-induced changes in
PIP
 
2
 
 mass in suspensions of N1E-115 neuroblastoma cells
with the results of single-cell measurements of PH-GFP
translocation. This extends our earlier work on the bradyki-
nin-induced InsP
 
3
 
 and Ca
 
2
 
 
 
 dynamics in these cells (Fink et
al., 1999a, 2000). In these works, we make extensive use of
the “Virtual Cell” modeling environment (Schaff et al.,
1997, 2001; Loew and Schaff 2001; Slepchenko et al.,
2002) to analyze the data and to develop a quantitative
mechanistic understanding of the system. We show that the
analysis predicts, and subsequent experiments confirm, an
initial stimulated increase in PIP
 
2
 
 concomitant with activa-
tion of PLC-mediated PIP
 
2
 
 hydrolysis. Furthermore, the ki-
netic analysis offers an approach toward reconciling the con-
flicting works on the behavior of PH-GFP.
 
Results
 
Phosphoinositide content in N1E-115 cells
 
Phosphoinositides, the majority of which include PI, lyso-
PI, PI 4-phosphate, and PIP
 
2
 
, are minor constituents of
membrane lipids in eukaryotic cells, yet play important
roles in signal transduction (Berridge and Irvine, 1984;
Payrastre et al., 2001). First, we determined the [
 
3
 
H]inosi-
tol incorporation into phosphoinositides that were sepa-
rated on oxalate-impregnated silica gel thin-layer plates us-
ing a developing solvent system of chloroform/methanol/
4 N NH
 
4
 
OH (45:35:10, vol/vol/vol). Over the first 24 h,
incubation of N1E-115 cells with [
 
3
 
H]inositol led to marked
changes in the distribution of 
 
3
 
H radioactivity in PI, lyso-
PI, PIP, and PIP
 
2
 
 under unstimulated conditions (unpub-
lished data). However, no significant differences between
cells labeled for 24, 44, 48, or 52 h were found under either
unstimulated or stimulated conditions (unpublished data).
Therefore, the phosphoinositide pools were believed to be
in equilibrium after 48 h incubation with [
 
3
 
H]inositol. As
shown in Table I, the Rf values of the four major phospho-
inositides were consistent with the Rf values previously re-
ported (Gonzalez-Sastre and Folch-Pi, 1968; Racagni et al.,
1992). The relative distribution of 
 
3
 
H radioactivity in PI,
lyso-PI, PIP, and PIP
 
2
 
 in the unstimulated N1E-115 cells
prelabeled with [
 
3
 
H]inositol for 48 h is also shown in Ta-
ble I. Although [
 
3
 
H]PI was the major component of
the [
 
3
 
H]phosphoinositide (85.4 
 
 
 
 2.8%), [
 
3
 
H]PIP
 
2
 
 and
 
Table I. 
 
Relative levels and Rfs of [
 
3
 
H]phosphoinositides in 
[
 
3
 
H]inositol-prelabeled N1E-115 cells determined by TLC
Radioactivity Rf
 
PI 100 
 
 
 
 0 0.49 
 
 
 
 0.02
Lyso-PI 12.6 
 
 
 
 3.0 0.41 
 
 
 
 0.02
PIP 2.4 
 
 
 
 0.3 0.27 
 
 
 
 0.01
PIP
 
2
 
2.8 
 
 
 
 0.8 0.11 
 
 
 
 0.02
[
 
3
 
H]phosphoinositide distribution in [
 
3
 
H]inositol-prelabeled N1E-115 cells
was prepared and analyzed as described in Materials and methods. Values
shown are mean 
 
 
 
 SEM of seven experiments.T
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[
 
3
 
H]PIP only represented 2.3 
 
 
 
 0.6% and 2.0 
 
 
 
 0.2%,
respectively (
 
n
 
 
 
 
 
 7). When labeled to equilibrium by
[
 
3
 
H]inositol, [
 
3
 
H]phosphoinositides have a similar distribu-
tion as the endogenous inositol lipids (Kaya et al., 1989).
Therefore, our paper indicates that PI is the most abundant
phosphoinositide in N1E-115 cells, whereas PIP and PIP2
occur in trace amounts only.
To examine the relative content of PIP2 in the cell mem-
brane, cells were labeled to equilibrium with [
32P]PO4
2 .
We used the same TLC system as described in the previous
paragraph to resolve PIP2 from the other phosphoinositides
(PI, PI 4-phosphate) and all other plasma membrane phos-
pholipids (Gonzalez-Sastre and Folch-Pi, 1968). Our data
showed that PIP2 comprised 0.43   0.02% of total cellular
phospholipids. We assume 50% of total cellular phospholip-
ids are present in the plasma membrane (Lange et al., 1989;
Warnock et al., 1993). Additionally, recent evidence from
one cell line indicates that  40% of total cellular PIP2 is
present in the plasma membrane (Watt et al., 2002). Thus,
the basal level of PIP2 can be estimated at 0.3% of phospho-
lipids in the plasma membrane. Furthermore, the percentage
of PIP2 relative to the phospholipids in the inner leaflet of
the plasma membrane would be 0.5% because 80% of PIP2
is found in the inner leaflet of the plasma membrane. As-
suming that phospholipids cover 60% of the inner surface
(Jain, 1980), and that a single lipid molecule occupies 70Å
2
(McLaughlin et al., 1981), a surface density of 4,000 mole-
cules/ m
2 for PIP2 can be estimated. This will be taken as
the basal level of PIP2; the basal levels of the other inositides
can then be calculated from Table I.
Bradykinin-induced decrease in membrane PIP2 level
On addition of a 1- M concentration of bradykinin that is
maximal for the bradykinin receptor-mediated InsP3 genera-
tion (Fink et al., 1999a, 2000), there was a relative decrease
of PIP2 (Fig. 1, black diamonds), which was detectable by
10 s, and reached a minimum ( 36.0   6.0%, n   5) by
20 s. Levels of [
3H]PIP2 recovered to basal levels in  150 s
in the continued presence of bradykinin. The rate of recov-
ery of PIP2 was much slower than that of InsP3, which
reaches its maximum before 10 s and returns to basal levels
by 30 s at 37 C (Fink et al., 1999a, 2000). Also shown in
Fig. 1 are the experimental data for PIP, which show rela-
tively little change after bradykinin stimulation.
It should be mentioned that, in some earlier works, abso-
lute PIP2 mass was determined by assay of InsP3 released
by alkaline hydrolysis (Willars et al., 1998). In our work,
[
3H]PIP2 mass was determined from the radioactivity of the
PIP2 spot on a silica gel TLC plate (Kaya et al., 1989; Racagni
et al., 1992; Lukacova and Marsala, 1997), which might con-
tain radioactivity from other doubly phosphorylated phos-
Figure 1. Experimental and simulated time courses of bradykinin-
induced changes of PIP2 and PIP in N1E-115 cells. [
3H]inositol-
prelabeled N1E-115 cells were incubated in the presence of 1  M 
bradykinin for the indicated times. Membrane lipids were extracted 
and analyzed as described in Materials and methods. Each data 
point is the mean   SEM of three to five experiments. All experiments 
were performed at RT. Black diamonds represent our initial 
determination of PIP2 changes; purple triangles are the PIP data. 
These data, along with our prior study of InsP3 dynamics in this cell, 
were used to constrain a model that produced the respective black 
and purple solid curves. The pathways that were modeled are 
shown in Fig. 2, and the model equations and parameters are 
described in the Appendix. The prediction of the model that there 
was an initial increase in [PIP2] led us to determine the change in 
PIP2 at 5 s, shown as a red diamond. The model calculation of the 
change in [InsP3] is shown in the inset.
Figure 2. Reaction scheme for the synthesis and hydrolysis of PIP2. 
The membrane-associated reactions are shown at the top, and the 
cytosol reactions on the bottom. These reaction schemes form the 
basis of the mathematical models that were developed to analyze 
the data. Details of the rate expressions for each of the reactions 
(shown in red) are provided in the Appendix.T
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phoinositides such as PI 3,4-bisphosphate. However, because
PIP2 is the predominant ( 99%) doubly phosphorylated
phosphoinositide in mammalian cells (Vanhaesebroeck et al.,
2001), the contribution to [
3H]PI(4,5)P2 radioactivity from
[
3H]PI(3,4)-bisphosphate should be negligible.
Bradykinin stimulates membrane PIP2 synthesis, 
resulting in an initial increase in PIP2
We analyzed the experiments in Fig. 1 using the Virtual Cell
software with a simple model consisting of a transient activa-
tion of PLC-mediated PIP2 hydrolysis followed by a slow re-
covery to basal levels via phosphorylation of PI and PIP (Fig.
2). Mathematical details of the model are provided in the
Appendix, along with a list of the parameters and how they
were chosen. The results of the simulation are shown in Fig.
1 so as to permit ready comparison to the experiment.
A key constraint on the model was the previously deter-
mined level and kinetics of InsP3 produced during bradyki-
nin-induced activation of PLC. Previous findings in this lab
indicated that bradykinin-induced generation of InsP3 in
N1E-115 cells reached its peak of several  M before 10 s
(Fink et al., 1999a, 2000). This previous work used quantita-
tive photorelease of caged InsP3 and calcium imaging to es-
tablish the amount of InsP3 required to attain a level of
calcium release equivalent to that obtained with maximal
stimulation with bradykinin. We also directly determined the
bradykinin-induced InsP3 kinetics using a combination of
modeling and direct biochemical InsP3 mass determinations.
In the present model, we adjusted some of the parameters to
reflect the slower kinetics of bradykinin-induced calcium dy-
namics (Xu and Loew, 2003) and slower InsP3 degradation at
RT. But our experimentally determined decrease of PIP2 sim-
ply couldn’t account for sufficient InsP3 unless a stimulated
synthesis of PIP2 was resupplying this substrate. This stimu-
lated synthesis was added to the model using PIP as the re-
quired precursor. However, because basal PIP was itself even
lower than PIP2 (Table I), PIP resupply through stimulated
phosphorylation of PI also had to be incorporated into the
model. PI is in abundant supply, so its depletion is insignifi-
cant and would not affect the kinetics of either PIP or PIP2.
The resultant model predicted a transient increase of PIP2
at times earlier than our initial experimental time points
(Fig. 1, the rise of the black simulation curve above the base-
line between 0 and 8 s). To investigate this possibility, we
measured the bradykinin-induced change in [
3H]PIP2 at 5 s.
Indeed, we found that bradykinin caused a relative increase
in [
3H]PIP2 (36.3   8.6%, n   3) compared with that be-
fore stimulation (Fig. 1, red diamond). To confirm that the
increase in PIP2 is due to PIP2 synthesis, we pretreated the
cells with micromolar wortmannin (30  M, 15 min). Wort-
mannin at nanomolar concentrations inhibits PI 3-kinases,
but at micromolar concentrations, it also inhibits the activity
of most PI 4-kinases (Nakanishi et al., 1995; Downing et al.,
1996). In cells treated with wortmannin, the increase in
[
3H]PIP2 at 5 s was abolished; instead, a relative decrease in
membrane PIP2 ( 5.1   1.1%, n   4) was obtained.
Bradykinin-induced PH-GFP translocation
Knowing that the kinetics of bradykinin-induced decrease in
membrane PIP2 and increase in cytosolic InsP3 were very
different in terms of both time-to-peak and recovery, we
tried to determine whether PH-GFP translocation mim-
icked changes in PIP2 or InsP3 in single cells. When ex-
pressed in N1E-115 cells, PH-GFP showed a strong ac-
cumulation at the plasma membrane and a low and
homogenous distribution in the cytosol (Fig. 3), consistent
with the idea that PH-GFP primarily binds to membrane
PIP2 at rest. Several explanations for the low resting intracel-
lular PH-GFP fluorescence are possible: (1) intracellular
pools of PIP2 are not accessible to PH-GFP (Balla et al.,
2000); (2) some intracellular PIP2 phosphatases (e.g., synap-
tojanin) have hydrolyzed the PIP2 on the internal mem-
branes and restricted the steady-state accumulation of PIP2
to the plasma membrane (Stefan et al., 2002); or (3) a signif-
icant amount of PIP2 is on the organelle membranes and can
bind PH-GFP (Watt et al., 2002), but its lower volumetric
density compared with the plasma membrane produces a
lower fluorescence. In this work, we measured fluorescence
from membrane GFP, segmented by a combination of
threshold operations and manual editing, and cytosolic fluo-
rescence regions of interest individually for each time point;
we did not use the more common procedure of measuring
the amplitude of the fluorescence signal at the plasma mem-
brane and cytosol region along a line across the cell for all
time points because we found that bradykinin could induce
cell shape changes, and hence, changes of the originally as-
signed membrane regions. After addition of bradykinin,
there was a decrease in plasma membrane PH-GFP fluores-
cence and a concomitant increase in cytosolic fluorescence
(Fig. 3 and Fig. 4). The maximum relative change in mem-
brane GFP fluorescence was  11.3    1.7% (n    19),
whereas the relative change in cytosolic fluorescence was
41.1   4.7% (n   19). The kinetics of bradykinin-induced
PH-GFP translocation is characterized by a rapid onset,
with translocation peaking at  20 to 30 s and returning to
the baseline in  3 min in the continued presence of brady-
Figure 3. Bradykinin-induced translocation of PH-GFP from the 
plasma membrane in a single N1E-115 cell. A single N1E-115 cell 
was stimulated with 1  M bradykinin. PH-GFP translocation was 
reflected as a decrease in the membrane GFP fluorescence and a 
concomitant increase in cytosolic fluorescence. The experiment 
was performed at RT. (A) Time series of images with the time indicated 
on each frame in seconds. Bradykinin was added at time 0 (after the 
third frame). (B) Relative change in GFP fluorescence at two locations 
in the cytosol of the cell in the images in A. Region 1 is indicated 
in the first frame of A by the rectangle just above the nucleus; region 
2 is indicated by the rectangle in the larger area of cytosol below 
the nucleus.T
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kinin (Fig. 3). This time course is very similar to the time
course of PIP2 hydrolysis detected biochemically from
[
3H]inositol-labeled cells, in line with the previous finding
that PH-GFP translocation primarily reports changes in
membrane PIP2 content (van der Wal et al., 2001). How-
ever, the bradykinin-induced PH-GFP translocation did not
exhibit an initial increase in PIP2, raising the possibility that
PH-GFP translocation might not be determined solely by
changes in membrane PIP2.
The expression level of PH-GFP may be an important fac-
tor in determining the extent to which membrane PIP2 and
cytosolic InsP3 affect the distribution of the PH-GFP. We
estimated intracellular GFP concentrations by comparing
the cytosolic fluorescence intensities of individual cells in
situ to those of a series of dilutions of purified GFP protein
of known concentration (see Materials and methods). The
basal levels of cytosolic PH-GFP ranged from 3 to 12  M,
with an average of 5.9   0.5  M (n   19). However, we
did not find any significant correlation between the basal cy-
tosolic PH-GFP concentration and either the time constants
or the amplitudes of the bradykinin-induced PH-GFP trans-
location, possibly because the range of PH-GFP expression
levels was not sufficient.
We elaborated the model used to analyze the biochemical
data on inositide turnover to see if it could also predict the
PH-GFP translocation experiments. The basal concentra-
tion of total PH-GFP in the cytosol (free plus bound to
InsP3) was taken as 6  M from our measurements. Binding
constants to InsP3 and PIP2 were taken from in vitro mea-
surements reported in the literature (Hirose et al., 1999).
Taken with the basal levels of InsP3 and PIP2, these deter-
mined the basal levels of the bound forms of PH-GFP.
Thus, all the additional model parameters were completely
based on measured values (albeit in vitro), and no parame-
ters were adjusted to fit the results of Fig. 4. All these param-
eters are provided in Table AII of the Appendix. The results
of a compartmental model, elaborated from the one used in
Fig. 1, are shown in Fig. 5. The results of a two-dimensional
spatial simulation, based on the geometry of one of the cells
of Fig. 3, are shown in Fig. 6.
The change in the cytosolic concentration in Fig. 5 and
the top row of Fig. 6 can be directly compared with the cor-
responding experimental results in Fig. 4 and Fig. 3, re-
spectively; this is because the intensity measured within a
confocal volume correctly reflects the concentration of a flu-
orophore whenever the confocal voxel is well within the
volume of the container that surrounds the fluorophore, i.e.,
the volume contained by the cell (Fink et al., 1998). We es-
timate our confocal volume to be  0.7   0.7  m within
the focal plane, and 2.1  m in the axial dimension. In our
experiments, we placed the focal plane near the center of the
cell, and the cell dimensions are significantly larger than
the confocal volume. However, this same consideration
precludes direct comparison of the measured fluorescence
change from the cell periphery and the simulation results
from the plasma membrane (Fig. 5, pink curve; Fig. 6, sec-
ond row). The confocal volume encompassing the thin
monolayer of membrane fluorescence also contains essen-
tially all of the adjacent cytosolic fluorescence. To account
for this, we estimated the total PH-GFP species within a
1- m
3 (0.7   0.7   2.1  m
3) volume encompassing the
membrane by adding the PIP2–PH-GFP molecules in a ver-
tical patch of membrane 0.7   2.1  m
2 to the PH-GFP and
IP3–PH-GFP in a 0.7   0.7   2.1  m
3 region adjacent to
the membrane. The relative change of this quantity is de-
picted in yellow in Fig. 5.
As can be seen, all three curves in Fig. 5 show that the
simulated translocation of PH-GFP only slightly reflects the
initial increase in PIP2 determined from both the model and
the experiment of Fig. 1. Of course, this initial increase is
still present in the simulation results for unbound PIP2 in
the presence of PH-GFP (shown for the spatial simulation
in Fig. 6). Indeed, the fact that the simulation results in Fig.
5 and Fig. 6 for the PH-GFP translocation are reasonably
Figure 4. Kinetics of bradykinin-induced PH-GFP translocation. 
The average changes in membrane and cytosol fluorescence after 
addition of 1  M bradykinin are plotted versus time. Each point was 
the mean   SEM of 19 experiments. Figure 5. Simulation of PH-GFP translocation. The compartmental 
model used in Fig. 1 was expanded to include PH-GFP binding. 
Additional parameters are in Table AII, and model equations are in 
the Appendix. The blue curve represents the relative change in total 
cytosolic GFP (free PH-GFP   InsP3–PH-GFP), and can be directly 
compared with the corresponding experimental results in Fig. 4. 
The pink curve corresponds to the relative change in PIP2–PH-GFP 
surface density on the plasma membrane. Because the confocal 
imaging system detects both fluorescence from the membrane and 
the adjacent cytosol, the PIP2–PH-GFP results were adjusted by 
an appropriate contribution from the total cytosolic signal in the 
yellow curve, as detailed in the text, to allow comparison with the 
experimental result in Fig. 4.T
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close to the experimental observations in Fig. 3 and Fig. 4
provides additional support for the overall model. Of course,
there are some discrepancies, and it would be important to
explore potential sources of error in the model. The most
important implicit assumptions in the model are that PH-
GFP–bound forms of both InsP3 and PIP2 are protected
from degradation. That is, as shown in Fig. 2, PIP2–PH-
GFP does not directly hydrolyze to InsP3, and IP3–PH-GFP
does not directly become degraded. This has the effect of
slowing inositide turnover by sequestering a dynamic frac-
tion in the PH-GFP bound forms. That the turnover of
these molecules is inhibited by PH-GFP is clear (Varnai and
Balla 1998), but that the extent of inhibition is complete in
both bound form may be an oversimplification. The as-
sumption of complete inhibition of InsP3 degradation in the
bound form is probably the primary source of the slower re-
covery of translocation in the simulation compared with the
experiment. Clearly, another important approximation of
the model is the application of in vitro biochemically deter-
mined Kd’s for binding of PH-GFP to InsP3 and PIP2 to an
analysis of in vivo experiments, but no in vivo measurements
are available. Additionally, the possibility of special binding
mechanisms in vivo has recently been suggested to explain
the different binding behavior of various PH isoforms (Var-
nai et al., 2002).
The results for the PH-GFP translocation in the spatial
model (Fig. 6, top row) also capture the features of the ex-
perimental results from that cell (Fig. 3, right-hand cell). In
particular, the nucleus creates a small diffusion barrier that
effectively creates a high surface-to-volume region of cytosol
to its upper right compared with the larger cytosolic region
below the nucleus. The nuclear diffusion barrier creates a
temporary buildup of released PH-GFP in the upper right
that is seen both experimentally (Fig. 3 B, compare the re-
spective plots for region 1 and 2) and in the simulation (Fig.
6; namely, the faster and higher rise of PH-GFP in that re-
gion of the cell revealed by the pseudocolor display in the
top row).
It is also instructive to compare the changes in PIP2 and
InsP3 in the presence of PH-GFP, shown in the bottom two
rows of Fig. 6, with the changes that the model calculates
when the PH-GFP is removed, shown in Fig. 7. The simula-
tion results in Fig. 7 are the result of simply setting the con-
centrations of all of the PH-GFP molecular species to zero
and are mathematically equivalent to the application of the
nonspatial model of Fig. 1 to our two-dimensional geome-
try. As can be seen, both the rates and the amplitudes of the
changes in InsP3 and PIP2 are severely reduced in the pres-
ence of 6  M PH-GFP, which effectively acts as a buffer for
both of these molecules. These simulations suggest that cau-
tion is required in interpreting the physiology of PH-GFP–
transfected cells. Indeed, the ability of PH-GFP to impede
access of PLC to PIP2 was recognized in one of the original
papers that described this probe (Varnai and Balla, 1998).
Figure 6. Results of an image-based spatial simulation of PH-GFP translocation after bradykinin-induced stimulation. The image of the cell 
on the right side of the images in Fig. 3 was used as the basis of the two-dimensional geometry. The cytosolic resting level of PH-GFP that was 
measured for this cell was 4.6  M, and this was the value used in the simulation. Other parameters were similar to the compartmental simulations 
(Table AI and Table AII). Details of the simulation are given in the Appendix. (Top row) Selected time points for the relative changes in total 
cytosolic PH-GFP (free   bound to InsP3). (Second row) Percent change in PH-GFP associated with PIP2 in the plasma membrane. (Third row) 
Concentration of free InsP3, indicated by the color bar in unit of  M, in the cytosol showing the buffering effect of PH-GFP as described in the 
text. (Fourth row) Surface density of PIP2, indicated by the color scale in molecules/ m
2, also showing the buffering effect of the indicator.T
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Whether PH 1-GFP inhibits InsP3-dependent calcium re-
lease has not been reported to our knowledge, although it
has been reported for another PH domain isoform (Varnai
et al., 2002).
Is PH-GFP translocation reporting changes 
in PIP2 or InsP3?
There has been considerable uncertainty in the literature as
to whether PH-GFP translocation monitors changes in PIP2
or InsP3 (Hirose et al., 1999; van der Wal et al., 2001).
Physiologically, a decrease in PIP2 will be accompanied by
an increase in InsP3, so it is difficult to know which is
the primary source for translocation of the probe from the
plasma membrane to the cytosol. Experiments where the
concentration of one molecule is clamped while the other
molecule is changed can give seemingly contradictory re-
sults. For example, microinjection of InsP3 led to transloca-
tion (Hirose et al., 1999), whereas photorelease of similar in-
tracellular concentrations from a caged precursor (van der
Wal et al., 2001) did not.
However, in our mathematical model, we can design
thought experiments in which each of these molecules is
clamped at its initial concentration, and then perform simu-
lations to see how the system would respond to the bradyki-
nin stimulus. The changes in total cytosolic PH-GFP from
such calculations are shown in Fig. 8, with the results for the
regular compartmental model shown for comparison. The
calculation labeled “Fixed InsP3” included all the reactions
in the regular model, but the concentration of InsP3 in the
cytosol was clamped to its initial value of 0.16  M; this is
equivalent to introducing a new InsP3 degradation mecha-
nism with a perfect feedback control to assure a rate that is
precisely tuned to maintain 0.16  M at all rates of PIP2 hy-
drolysis. Similarly, the calculation labeled “Fixed PIP2”
clamps the PIP2 surface density at its initial value of 4,000
molecules/ m
2, while allowing InsP3 production to proceed
at a rate identical to that in the regular model. As can be
seen, both of these circumstances produce significant trans-
location of the probe, suggesting that PH-GFP translocation
is independently sensitive to both changes in PIP2 and InsP3.
Of the two cases, the change in InsP3 (i.e., clamped PIP2)
produces a PH-GFP translocation that is closer to that pro-
duced by the full simulation. However, it should be empha-
sized that these results would be particularly sensitive to the
relative affinities of the probe for InsP3 vs. PIP2, and again
the values were taken from in vitro experiments.
We also used the model to examine the contrasting results
that were reported when InsP3 is introduced into cells in the
absence of receptor-mediated activation of PLC. Hirose et al.
(1999) reported that injection of 1  M InsP3 could produce
large translocation of PH-GFP, whereas van der Wal et al.
(2001) used photorelease of caged InsP3 to reach the opposite
conclusion. Fig. 9 shows a series of simulations of the translo-
cation response to a 1- M instantaneous bolus of InsP3 at
time 0 in the absence of phosphoinositide turnover. The three
traces correspond to differing initial concentrations of total
cytosolic PH-GFP, with the central concentration (6  M)
corresponding to the average concentration of the probe mea-
sured in our experiments. As can be seen, the translocation
produced by 1  M InsP3 in the presence of 6  M total cyto-
solic PH-GFP is predicted to be much smaller than that pro-
Figure 7. Results of an image-based spatial simulation of phosphoinositide turnover after bradykinin-induced stimulation. The simulations 
were performed as in Fig. 6, except that PH-GFP was not included in the system. (Top row) Concentration of InsP3 in the cytosol. (Second 
row) Selected time points for the surface density of PIP2. The same scales were used as in the bottom two rows of Fig. 6 to facilitate comparison.
Figure 8. Compartmental simulations with fixed InsP3 or PIP2. 
The model of Fig. 5 was used, except that InsP3 (green) or PIP2 (blue) 
are clamped at their initial values. Only the change in total cytosolic 
PH-GFP is shown because this is the only model output that may 
be directly compared with the corresponding experimental result 
(shown in Fig. 4) as explained in the text. Also shown for comparison 
is the result produced by the full model in which all molecules are 
allowed to vary (black curve).T
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duced in the full model of receptor-activated phosphoinosi-
tide turnover (Fig. 8, black trace). However, the effect is very
sensitive to the expression level of the indicator over a 10-fold
range. Hirose et al. (1999) and van der Wal et al. (2001) did
not report the concentrations of indicator in their respective
experiments. So, the difference in their results may be a conse-
quence of a low PH-GFP expression level in the former and a
high expression level in the latter. In conclusion, our results
suggest that the relative or percent change in translocation af-
ter stimulated phosphoinositide turnover will be higher with
lower concentrations of PH-GFP, when the PH-GFP will not
buffer a significant fraction of either membrane PIP2 or cyto-
solic IP3. However, at very low concentrations, the intensity of
the fluorescence may, of course, become limiting.
Discussion
In this paper, we showed that bradykinin induced first an in-
crease, then a decrease, in membrane PIP2 in N1E-115 neu-
roblastoma cells. Micromolar wortmannin, which blocks
most PI 4-kinases (Nakanishi et al., 1995; Downing et al.,
1996) and PI 3-kinases, completely abolished the initial in-
crease and even revealed an immediate decrease in PIP2. Be-
cause PI 4-kinases are required for PIP2 synthesis, these
results could indicate that bradykinin leads to a rapid activa-
tion of PIP2-synthesizing kinases, and that this effect pre-
cedes the hydrolysis of PIP2 mediated by PLC. The rapid
synthesis of PIP2 can also explain why the maximum de-
crease in PIP2 occurs at 20 s, 10 s behind the maximum in-
crease in both InsP3 and intracellular Ca
2  concentration
(Fink et al., 1999a, 2000; Xu and Loew, 2003). Bradykinin
binds to B2 receptor (Coggan and Thompson, 1995, 1997)
in N1E-115 cells, which use a GTP-binding protein, Gq, to
activate phospholipase C 1. Whether bradykinin uses the
same signal pathway to activate PI 4-kinase and PLC is not
known. It should be pointed out, though, that a decrease in
the activity of PIP2 phosphatases could also lead to an in-
crease of PIP2. Whether bradykinin inhibits PIP2 phos-
phatase in N1E-115 cells remains to be determined.
Consistent with our findings, Yorek et al. (1994) found
that bradykinin stimulated 
32P incorporation into PIP and
PIP2 as well as InsP3 release in neuroblastoma cells. Simi-
larly, it was found that binding of thrombin to its receptors
caused a synthesis of PIP and PIP2, preceded by degradation
of these phosphoinositides in platelets (Lassing and Lind-
berg, 1990). In fibroblasts, net synthesis of the phospho-
inositides was revealed when hydrolysis of PIP2 was blocked
by neomycin (Carney et al., 1985). Also in fibroblasts,
Chahwala et al. (1987) found that the GTP S-stimulated
hydrolysis of PIP2 concomitant with an increase in InsP3
that was 10 times over the decrease in PIP2, suggesting PIP2
synthesis was also accelerated after GTP S addition. In a
very different system, it was shown in sea urchin (Turner et
al., 1984) and Xenopus (Snow et al., 1996) eggs that inositol
lipid levels increased on fertilization, but this may be due to
a later event associated with cortical granule exocytosis, as
has been recently shown for mouse egg fertilization (Halet et
al., 2002). In any case, the generality of a concurrent recep-
tor-mediated stimulation of PIP2 hydrolysis and synthesis is
certainly not established. This may be because the early tran-
sient nature of the phenomenon, as well as its unexpected-
ness, has made it elusive.
We further investigated the turnover of phosphoinositides
by following the translocation of PH-GFP. In unstimulated
cells, the PH-GFP was concentrated at the plasma mem-
brane as seen before (Stauffer et al., 1998; Varnai and Balla,
1998; Holz et al., 2000; van der Wal et al., 2001), indicating
it preferentially binds to the plasma membrane PIP2, possi-
bly because there is a much higher cellular concentration of
PIP2 in the plasma membrane (4  M in our cells and  10
 M in general; McLaughlin et al., 2002) than cytosolic
InsP3 in N1E-115 cells (0.16  M; Fink et al., 1999a). PH-
GFP translocation induced by bradykinin showed similar ki-
netics as the membrane PIP2 change measured by TLC, con-
sistent with the finding of van der Wal et al. (2001) that
PH-GFP primarily reported membrane PIP2. However, the
initial increase in membrane PIP2 was not reflected in PH-
GFP translocation. There may be several explanations for
this discrepancy. First, overexpression of PH-GFP may in-
terfere with cellular signals and inhibit synthesis of PIP2.
However, simultaneous recording of PH-GFP translocation
and intracellular Ca
2  in N1E-115 cells showed that PH-
GFP translocation also lagged behind the increase in intra-
cellular Ca
2  induced by bradykinin (van der Wal et al.,
2001), which correlated spatiotemporally with the InsP3 in-
crease (Fink et al., 1999a, 2000), suggesting synthesis of
PIP2 was still stimulated in the presence of PH-GFP. An-
other possible explanation is that PH-GFP translocation can
be affected by both membrane PIP2 and cytosolic InsP3, and
the translocation induced by the initial synthesis of PIP2 is
masked by binding of PH-GFP to increased InsP3. There is
compelling evidence that PH-GFP can monitor InsP3 under
some circumstances (Hirose et al., 1999; Nash et al., 2001;
Okubo et al., 2001) in that the amount of InsP3 increase
produced by PIP2 hydrolysis is by itself sufficient to induce
PH-GFP translocation. However, in the work of van der
Wal et al. (2001), it was found that interfering with PIP2 re-
synthesis, but not InsP3 generation, changed the kinetics of
PH-GFP translocation in N1E-115 cells; this supports the
Figure 9. Compartmental simulation of the response of the 
steady-state system to an instantaneous bolus of 1  M InsP3. 
The same compartmental model was used, except that the bradykinin 
stimulus was never applied. Instead, InsP3 was stepped from the 
basal level of 0.16  M to 1.16  M at time 0. This was equivalent 
to a rapid injection or a pulse of photorelease. The response of 
PH-GFP translocation is displayed for three initial total cytosolic 
concentrations of the indicator. The central value of 6  M (blue 
curve) corresponds to the average expression level in our cells.T
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idea that PH-GFP monitors PIP2. In both our experiments
(Fig. 4) and simulations (Fig. 5), the initial fast increase in
PIP2 is not reflected in the PH-GFP translocation, but the
overall time course does more closely resemble the behavior
of PIP2 than InsP3.
A thorough analysis of the model helped to resolve some
of these apparent contradictions, showing that PH-GFP
translocation is sensitive to physiologically relevant changes
in both InsP3 and PIP2. First, the model results for PH-GFP
translocation (Fig. 5 and Fig. 6) produce reasonably good
agreement with the experiment (Fig. 3 and Fig. 4). Because
the parameters associated with PH-GFP binding to InsP3
and PIP2 were taken directly from the literature, and no pa-
rameters were adjusted to accommodate the incorporation
of PH-GFP translocation into the phosphoinositide turn-
over model of Fig. 1, the close agreement between experi-
ment and simulation is further support for the hypotheses
that underlie the model. The model does reveal that translo-
cation is sensitive to both InsP3 and PIP2 (Fig. 8), and that
the presence of the indicator distorts the amplitude and time
course of changes in both of these molecules through a buff-
ering effect (compare Fig. 6 with Fig. 7). That this buffering
effect can, in turn, severely diminish the sensitivity of the
translocation to changes in phosphoinositide levels was illus-
trated in Fig. 9, where a 1- M change in InsP3 was calcu-
lated to give an insignificant translocation at high PH-GFP
concentrations. Therefore, we suggest the expressed PH-
GFP be kept at low concentrations so as not to buffer a sig-
nificant fraction of either PIP2 or IP3. By highlighting the
sensitivity of the assay to PH-GFP expression level, Fig. 9
could also help to explain the apparent conflicts in the litera-
ture on the amount of translocation elicited by InsP3 alone
(e.g., Hirose et al., 1999; van der Wal et al., 2001). It should
also be pointed out that the receptor-mediated PLC activa-
tion may produce vastly differing amounts of InsP3 for a
given change in PIP2 surface density in the plasma mem-
brane in different cell lines. This would depend on the sur-
face-to-volume ratio and the contribution of stimulated PIP2
synthesis. For example, we have shown that bradykinin
stimulates only a few hundred nM InsP3 in a smooth muscle
cell line even though this is still sufficient to elicit robust cal-
cium release from the ER (Fink et al., 1999b). With differ-
ing initial concentrations and differing surface-to-volume ra-
tios, the translocation behavior of PH-GFP would have to
be analyzed for each cell system to dissect the sensitivity to
PIP2 vs. InsP3.
We wish to conclude by emphasizing that this paper ex-
emplifies the value of combining quantitative models with
quantitative experiments. The initial results of our TLC ex-
periments (Fig. 1, black diamonds) could only be fit to a
model that predicted an initial increase in PIP2. The hy-
pothesis that was generated from this modeling result then
prompted us to take an additional early experimental time
point (Fig. 1; red diamond) that confirmed the prediction.
But additional experiments using the PH-GFP transloca-
tion assay on individual cells (Fig. 3 and Fig. 4) failed to re-
veal this initial increase in PIP2. However, an expanded
model that included binding of PH-GFP to both PIP2 and
InsP3 based on in vitro literature binding constants (Fig. 5
and Fig. 6) was largely consistent with the experiments, fail-
ing also to reveal an initial increase in PH-GFP association
with the membrane even though the initial increase in PIP2
was still present. Thus, the modeling result showed that the
PH-GFP translocation experiment could not be used to ar-
gue against our initial hypothesis; indeed, it further sup-
ported it. Once we had this model, we could use it to visu-
alize molecules that were not accessible experimentally (the
spatiotemporal cellular distribution of PIP2 and InsP3 either
in the presence, Fig. 6, or absence, Fig. 7, of PH-GFP). The
model also allowed us to perform thought experiments
(Fig. 8 and Fig. 9) that helped illuminate an important con-
troversy in the literature on how to interpret results from
this valuable and increasingly accepted live-cell assay for
phosphoinositide turnover.
Materials and methods
Preparation and treatment of cells prelabeled with [
3H]inositol
N1E-115 cells were grown to 30–40% confluency in 35-mm culture
dishes. Approximately 4   10
5 cells per culture dish were incubated with
4  Ci/ml of myo-[2-
3H]inositol (PerkinElmer) in Eagle’s basal medium con-
taining 0.5% dialyzed heat-inactivated FBS for 48 h. After two rinses to re-
move the unincorporated 
3H radioactivity, the cells from each culture dish
were scraped and suspended in 1 ml Eagle’s balanced salt solution (EBSS).
A 0.5-ml portion was homogenized and used for protein assay. Aliquots of
1.0 ml were transferred to 12-ml disposable screw cap polypropylene cen-
trifuge tubes and used for each timed incubation (0, 5, 10, 20, 30, 60, 120,
and 150 s) with EBSS containing 1  M bradykinin. The incubation was ter-
minated by pipetting 2 ml methanol to the tube. Then, 3 ml chloroform
was added, followed by 1 ml 2.4 N HCl. The mixture was suspended by
vortexing, and was centrifuged at 400 g for 10 min to separate the aqueous
and organic phases. The lower layer was withdrawn, and the aqueous
phase was reextracted with 2 ml chloroform. The two organic extracts
were combined.
[
3H]phosphoinositide analysis
Separation of phosphoinositides was performed as described by Kaya et al.
(1989). In brief, the lipid solution was dried under N2, redissolved in chlo-
roform/methanol (7:3, vol/vol) and applied to a TLC plate (LK5D, What-
man) impregnated with 1% potassium oxalate and 2 mM EDTA, followed
by development with an alkaline solvent system of chloroform, methanol,
and 4 N NH4OH (45:35:10, vol/vol/vol; Gonzalez-Sastre and Folch-Pi,
1968) to separate phosphoinositides. All procedures were conducted at
RT. The phosphoinositides were identified by co-migration with authentic
lipid standards that were visualized with phosphomolybdic acid spray re-
agent (Sigma-Aldrich). The silica gel area containing radioactivity was
scraped, incubated with 100  l Soluene
®-350 overnight (Packard Instru-
ment Co.), and then suspended in CytoScint ES (ICN Biomedicals) and as-
sayed for radioactivity with a scintillation counter (model 2000 CA; Pack-
ard Instrument Co.). After treatment with Soluene
®-350, recovery of the 
3H
radioactivity applied to the silica gel was almost 100%.
[
32P]PIP2 analysis
To examine the relative PIP2 content of membrane, N1E-115 cells were
grown to 30–40% confluency in 35-mm culture dishes. Approximately
4   10
5 cells per culture dish were labeled to equilibrium (48 h) with 25
 Ci/ml [
32P]PO4 (carrier free; ICN Biomedicals) at 37 C in EBSS. After
washing twice to remove the unincorporated 
32P, the cells were scraped
and suspended with EBSS. Cell lipids were extracted with acidic chloro-
form-methanol as described previously (Agranoff et al., 1983). A 20- l ali-
quot of the lipid extract was subjected to TLC using TLC plates (LK5D;
Whatman) impregnated with 1% potassium oxalate and 2 mM EDTA, and
the mobile phase chloroform/methanol/4 N NH4OH (45:35:10; Gonzalez-
Sastre and Folch-Pi, 1968). Radioactive bands were identified by co-chro-
matography of a PIP2 standard. TLC spots were transferred to scintillation
vials, suspended in CytoScint ES (ICN Biomedicals), and radioactivity was
determined by liquid scintillation counting (model 2000 CA scintillation
counter; Packard Instrument Co.). A second 20- l aliquot of the lipid ex-
tract was applied to a piece of silica gel scraped from a blank TLC plate
with area similar to the scraped PIP2 spots, and suspended in CytoScint ES
to determine radioactivity of the total lipids spotted.T
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Cell culture and transfections
N1E-115 neuroblastoma cells were seeded in 35-mm culture dishes at
 15,000 cells per dish on 22-mm glass coverslips, and cultured in 2.5 ml
of DME supplemented with 10% FCS and antibiotics. PH-GFP constructs
(Stauffer et al., 1998; a gift from Dr. Kees Jalink, The Netherlands Cancer
Institute, Amsterdam, Netherlands) were transfected for 3 h using Lipo-
fectAMINE™ at 1  g DNA/dish. After transfection, cells were incubated in
DME containing 0.5% FBS and 1% DMSO for 36–48 h.
Confocal microscopy and image analysis
For confocal imaging, culture dishes with coverslips were mounted on an
inverted confocal microscope (LSM 510; Carl Zeiss MicroImaging, Inc.)
equipped with a 63  1.40 oil objective (Plan-Apochromat
®; Carl Zeiss Mi-
croImaging, Inc.). Excitation of GFP was with the 488-nm argon ion laser-
line, and GFP fluorescence from the PH-GFP fusion protein was recorded
through an emission filter (LP505; Carl Zeiss MicroImaging, Inc.). For all
experiments, the pinhole size was kept the same (axial resolution of  1.2
 M). Bradykinin was added in 20- l aliquots to the culture dish, so that
the addition (final concentration was 1  M) was nearly instantaneous, but
with as little cellular disturbance as possible. For translocation studies, a
series of confocal images were taken at 5-s intervals. Direct determination
of the ratio of membrane to cytosolic fluorescence by post-acquisition
linescan profiles across each of the cells was confounded by the shape
changes of cells during experiments (see Results). Using MetaMorph
® soft-
ware (Universal Imaging Corp.), a region of interest was assigned for each
cell including part of the membrane, cytosol, and background. To measure
the fluorescence of the membrane section inside a region of interest, a
thresholding step was used to segment the membrane region, and the aver-
age fluorescence above this threshold was measured as the membrane flu-
orescence. The same region of interest and threshold were then applied for
each image in a series. We found this approach could resolve the problem
caused by cell movements and shape changes, and let us reliably detect
changes in membrane fluorescence. The cytosolic fluorescence was mea-
sured by directly assigning regions of interests for cytosol.
Quantitation of cytosolic PH-GFP levels
The cytosolic PH-GFP concentration was determined in situ by using cali-
bration slides containing known concentrations of purified, bacterially ex-
pressed PH-GFP (a gift from Dr. Laurinda Jaffe, University of Connecticut
Health Center, Farmington, CT, and Dr. Tamas Balla, National Institutes of
Health, Bethesda, MD). The purity of PH-GFP protein was confirmed by
SDS-PAGE analysis, and the stock concentration (1  g/ l) was measured
by the BCA Protein Assay (Pierce Chemical Co.). Calibration slides were
made by preparing various dilutions of the stock PH-GFP in EBSS, and im-
aging the fluorophore between two coverslips with the same parameters as
used for the cellular PH-GFP imaging (Fink et al., 1998).
Computational modeling
The Virtual Cell software environment (available at http://www.
nrcam.uchc.edu) was used to develop a model of PIP2 turnover. The math-
ematical details of the model are provided in Fig. 2 and the Appendix. The
model may be accessed and copied by logging in to the Virtual Cell and
opening the “published” model called “PIP2 hydrolysis.” This will permit
visualization of the time course and/or spatial distribution of all the vari-
ables in the model including those that were not presented in this paper.
A set of instructions for downloading the model in either an XML-compli-
ant format or as in the VCMDL format is available at http://www.
nrcam.uchc.edu/applications.html.
Appendix
Model equations and parameters
The reactions labeled in red in Fig. 2 are governed by the rates as follows:
Brackets, [], surround molecular species that are variables in the model.
Plasma membrane species are designated by PM suffixes, and cytosolic
species with Cyt suffixes.
PIPsyn: (Ratebasal_PIPsyn   Ratestim_PIPsyn) * [PI_PM]
Ratestim_PIPsyn   kStimSynPIP * exp( ((t   tauPIPsyn)/PIPsyndecay)) * 
(t   tauPIPsyn)
Ratebasal_PIPsyn   (kBasalSynPIP * 0.581 * ( 1.0   exp(((PIP_init   
[PIP_PM])/PIP_init)))) * ([PIP_PM]   PIP_init)
PIP2syn: (Rate_PIP2Synbasal   Rate_PIP2SynStim) * [PIP_PM]
Rate_PIP2SynStim   kStimSynPIP2 * exp( ((t   tauPIP2syn)/PIP2syndecay)) 
* (t   tauPIP2syn)
Rate_PIP2Synbasal   (kBasalSynPIP2 * 0.581 * ( 1.0   exp(((PIP2_basal – 
[PIP2_PM])/PIP2_basal)))) * ([PIP2_PM]   PIP2_basal)
PLCact: (kfPLCact * ([PLC_PM] * signal))   (krPLCact * [PLC_act_PM])
Signal   (t   tau0) * exp( ((t   tau0)/stimdecay))
PIP2_hyd: k_PIP2hyd * [PIP2_PM] * [PLC_act_PM]
PIP2_PH: (kf_PIP2PH * [PH_GFP_Cyt] * [PIP2_PM])    (kf_PIP2PH *
Kd_PIP2PH * [PIP2_PHGFP_PM])
Table AI. Parameter values for the simulation in Fig. 1
Parameter Value Comments
IP3_basal 0.16  M Fink et al., 1999a, 2000
IP3_Diff 283  m
2/s Allbritton et al., 1992
KfPLCact 5.0E-4 s
 1 Best fit to Fig. 1
PIP2_basal 4,000.0 molecules/ m
2 Measured
PIP2syndecay, 
PIPsyndecay, stimdecay
2,857.0 molecules/ m
2 Best fit to Fig. 1 and appropriate for required rate 
of InsP3 production
PIP_basal 1.0 s Measured
PI_PM_init 142,857.0 molecules/ m
2 Measured
PLC_PM_init 100.0 molecules/ m
2 Best fit to Fig. 1 (dependent on kfPLCact)
PLC_act_PM_init 0.0 molecules/ m
2 Basal activity is implicit in maintenance of basal InsP3 
of 0.16  M
SurfToVol_NM 1.0 Spherical nucleus of radius 3  m
SurfToVol_PM 0.5 Calculated for a hemispherical cell of radius 9  m; 
the N1E-115 neuroblastoma cells are often significantly 
larger, but their many processes and convoluted 
membrane makes this a good estimate
kBasalSynPIP 0.0055 s
 1 Chosen to maintain near-constant supply of PIP
kBasalSynPIP2 0.048 s
 1 Chosen to reproduce recovery phase of PIP2 (Fig. 1)
kIP3deg 0.08 s
 1 Based on value of 0.16 s
 1 at 37 C from Fink et al. (1999a)
kStimSynPIP 0.019 s
 1 Fit to experimental data in Fig. 1
kStimSynPIP2 0.92 s
 1 Fit to experimental data in Fig. 1
k_PIP2hyd 2.4 (s molecules/ m
2)
 1 Appropriate for required rate of InsP3 production
krPLCact 0.1 s
 1 Appropriate for required rate of InsP3 production
tau0, tauPIP2syn, tauPIPsyn 0.05 s Stimulation introduced at 50 msT
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IP3_PHGFP: (kf_IP3PH * [PH_GFP_Cyt] * [IP3_Cyt])   (kf_IP3PH * KdIP3PH
* [IP3_PHGFP_Cyt])
IP3deg: kIP3deg * ([IP3_Cyt]   IP3_basal)
IP3_uncaging: intensity * [IP3X_Cyt] * [hv_Cyt]
The rate of change of any molecular species is given by the sum of all
the individual reaction rates that produce it minus all the rates that degrade
it. For a spatial model, diffusion of molecules in the cytosol also has to be
to be taken into account. For example, the partial differential equation
governing the temporal and spatial variation of InsP3 is:
For compartmental (i.e., nonspatial) models, diffusion is considered to
be instantaneous on the time scale of interest, and the equations reduce
to a set of ordinary differential equations containing just the reaction
rates with appropriate adjustments for the surface-to-volume ratio of the
plasma membrane to the cytosol (SurfToVol_PM). Both spatial and com-
partmental models for the pathways in Fig. 2 were developed in this
work. The set of ordinary differential equations generated for the com-
partmental models were solved numerically using the LSODA stiff solver
(variable time step) available within the Virtual Cell. Spatial models were
solved with the finite volume method using a time step of 1 ms and a
two-dimensional spatial mesh of 116   172 elements (x,y), each with di-
mensions of 0.42   0.42  m. A fourfold correction for the lower surface-
to-volume ratio of the two-dimensional geometry compared with the ac-
tual three-dimensional geometry of the cell was also included in the
model. The model and all the simulation results may be examined by
logging into the Virtual Cell at http://www.nrcam.uchc.edu; the model is
named “PIP2 Hydrolysis” and can be accessed by unchecking “Private
only” under the “View menu.” By copying the model into a new work-
space, the reader may modify the model by changing parameters or add-
ing new model components.
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